HealthFortuneabout 1 hour ago
FDA Faces Decision on Multi-Cancer Blood Test
6 min read
The FDA is considering approval of Galleri, a multi-cancer early detection blood test by GRAIL. The test analyzes blood signals to screen for many cancers simultaneously, aiming to catch diseases like pancreatic and ovarian cancer before symptoms appear.
Level
Hype check
Tap to vote and see what everyone thinks.